LEADER 03900nam  22006855  450 
001 9910370058803321
005 20200630075705.0
010   $a981-10-5640-4
024 7 $a10.1007/978-981-10-5640-6
035   $a(CKB)4100000009382589
035   $a(DE-He213)978-981-10-5640-6
035   $a(MiAaPQ)EBC5910124
035   $a(EXLCZ)994100000009382589
100   $a20190930d2020      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLife in Pain $eAffective Economy and the Demand for Pain Relief /$fby John L. Fitzgerald
205   $a1st ed. 2020.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020.
215   $a1 online resource (XIII, 195 p. 18 illus., 14 illus. in color.) 
311   $a981-10-5639-0 
320   $aIncludes bibliographical references.
327   $aChapter 1: Introduction -- Chapter 2: The extended pain neuromatrix -- Chapter 3: Oxycodone epidemic -- Chapter 4: Global cannabis markets -- Chapter 5: Over-the-counter (OTC) consumers over a barrel -- Chapter 6: Affective economy -- Chapter 7: Reconceptualising the demand for pain relief -- Chapter 8: Regulating pain, regulating drug markets and harm reduction -- Chapter 9: Conclusion.
330   $aThis book explores pain in a number of ways. At the heart of the book is an extension of Melzack?s neuromatrix theory of pain into the social, cultural, and economic fields. Specific assemblages involving varied institutions, flows of capital, encounters, and social and economic structures provide a framework for the formation of pain, its perception, experience, meaning, and cultural production. Complementing the extended neuromatrix is a second theory, focussed on the propensity of western market capitalism to seek out new areas of life to subsume to capital. Pain is one such life area that is now ripe for exploitation. Although the book has theory at its heart, it draws extensively on case studies to identify the contradictions and complexities. Case studies are drawn from accounts of drug use in varied contexts such as prescription drugs, methamphetamine use, oxycodone use in North America, and the global rise of the medicinal cannabis marketplace. .
606   $aMedical anthropology
606   $aPain medicine
606   $aCrime?Sociological aspects
606   $aPharmacy management
606   $aSocial policy
606   $aCultural studies
606   $aMedical Anthropology$3https://scigraph.springernature.com/ontologies/product-market-codes/X12080
606   $aPain Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H47003
606   $aCrime and Society$3https://scigraph.springernature.com/ontologies/product-market-codes/1B3000
606   $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020
606   $aSocial Policy$3https://scigraph.springernature.com/ontologies/product-market-codes/W34020
606   $aCultural Studies$3https://scigraph.springernature.com/ontologies/product-market-codes/X22040
615  0$aMedical anthropology.
615  0$aPain medicine.
615  0$aCrime?Sociological aspects.
615  0$aPharmacy management.
615  0$aSocial policy.
615  0$aCultural studies.
615 14$aMedical Anthropology.
615 24$aPain Medicine.
615 24$aCrime and Society.
615 24$aPharmacoeconomics and Health Outcomes.
615 24$aSocial Policy.
615 24$aCultural Studies.
676   $a306.461
700   $aFitzgerald$b John L$4aut$4http://id.loc.gov/vocabulary/relators/aut$0193106
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910370058803321
996   $aLife in Pain$92201420
997   $aUNINA